These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 37333508)

  • 1. SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes.
    Wander PL; Lowy E; Korpak A; Beste LA; Kahn SE; Boyko EJ
    Diabet Epidemiol Manag; 2023; 11():100151. PubMed ID: 37333508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection.
    Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Kahn SE; Boyko EJ
    Diabetes Care; 2022 Apr; 45(4):782-788. PubMed ID: 35085391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study.
    Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Kahn SE; Danaei G; Boyko EJ
    BMJ Open; 2022 Mar; 12(3):e058363. PubMed ID: 35304400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study.
    Bohnert AS; Kumbier K; Rowneki M; Gupta A; Bajema K; Hynes DM; Viglianti E; O'Hare AM; Osborne T; Boyko EJ; Young-Xu Y; Iwashyna TJ; Maciejewski M; Schildhouse R; Dimcheff D; Ioannou GN
    BMJ; 2023 May; 381():e074521. PubMed ID: 37220941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.
    Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR
    JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COVID-19 Infection With Incident Diabetes.
    Naveed Z; Velásquez García HA; Wong S; Wilton J; McKee G; Mahmood B; Binka M; Rasali D; Janjua NZ
    JAMA Netw Open; 2023 Apr; 6(4):e238866. PubMed ID: 37071420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19.
    Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Young BA; Boyko EJ
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34083248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
    Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
    JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study.
    Ioannou GN; Locke ER; O'Hare AM; Bohnert ASB; Boyko EJ; Hynes DM; Berry K
    Ann Intern Med; 2022 Mar; 175(3):352-361. PubMed ID: 34928700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection.
    Corcillo A; Saqib A; Sithamparanathan N; Khanam A; Williams J; Gulati A; Kariyawasam D; Karalliedde J
    Int J Endocrinol; 2022; 2022():8030765. PubMed ID: 35256883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022.
    Bajema KL; Wang XQ; Hynes DM; Rowneki M; Hickok A; Cunningham F; Bohnert A; Boyko EJ; Iwashyna TJ; Maciejewski ML; Viglianti EM; Streja E; Yan L; Aslan M; Huang GD; Ioannou GN
    JAMA Netw Open; 2022 Nov; 5(11):e2241434. PubMed ID: 36367727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19.
    Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Kahn SE; Boyko EJ
    Diabetes Care; 2021 Dec; 44(12):2708-2713. PubMed ID: 34615690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system.
    Ioannou GN; Locke ER; Green PK; Berry K
    EClinicalMedicine; 2022 Mar; 45():101326. PubMed ID: 35261970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
    Nordström P; Ballin M; Nordström A
    Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.
    Al-Rifai RH; Alhosani F; Abuyadek R; Atef S; Donnelly JG; Leinberger-Jabari A; Ahmed LA; Altrabulsi B; Alatoom A; Alsuwaidi AR; AbdelWareth L
    Front Med (Lausanne); 2022; 9():1092646. PubMed ID: 36703898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.